Wednesday, October 27, 2021
Home Tags Department of Pharmaceuticals

Tag: Department of Pharmaceuticals

Govt extends timeline to apply for PLI scheme

The Department of Pharmaceuticals (DoP) has extended the deadline for submission of application for the production linked incentive (PLI) scheme for pharmaceuticals...

Govt to come up with FAQs on PLI scheme soon

The Department of Pharmaceuticals (DoP) is in the process of compiling and publishing a list of Frequently Asked Questions (FAQs) based on...

PLI Scheme: Approvals accorded for Promotion of APIs

The Department of Pharmaceuticals, with an objective to attain self-reliance and reduce import dependence in critical Bulk Drugs - Key Starting Materials...

Govt issues revised guidelines under PLI scheme for Medical Devices

The Department of Pharmaceuticals (DoP) has issued revised guidelines under the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical...

High Court: Ensure immediate supply of Tocilizumab

In view of the "acute shortage" of Tocilizumab which is prescribed to a large number of C-19 patients, the Delhi High Court has directed the Union Health...

India bans export of Remdesivir drug

As C-19 cases surge in the country , the government of India on Sunday ordered prohibition on the export of Remdesivir drug...

19 Medical Devices added to public procurement policy: DoP

The Department of Pharmaceuticals (DoP) has incorporated 19 medical devices in the revised guidelines of the public procurement policy. The revised order...

Drug Price Control: A Double Edged Sword: Article

In May 2013, the Department of Pharmaceuticals (DoP) of India brought 348 medicines— essential and lifesaving drugs from the National List of Essential Medicines (NLEM)—under price control by...

NPPA: 8,200 Cr outstanding amount related to 880 overcharging cases pending

Total outstanding amount of Rs. 8,200 crore related to 880 overcharging cases of Drug Prices Control Order (DPCO) violations are pending with...

Medical x-ray machines: DoP to promote domestic manufacturing

The Department of Pharmaceuticals (DoP) has prepared a phased manufacturing programme (PMP) in consultation with department of revenue (DoR) to promote domestic...

Govt issues environmental clearance for Bulk Drugs

The Union environment ministry has finally issued environmental clearance for active pharmaceutical ingredients (APIs) and intermediates as single category instead of individual...

Pharma industry a ‘Strategic Sector’: Parliamentary panel

New Delhi: Highlighting the need for strong indigenous pharma companies, a Parliamentary panel has recommended that the pharma industry should be categorised as a "strategic sector"...

DoP proposal: One time settlement for overcharging disputes

The Department of Pharmaceuticals (DoP) has proposed draft framework of Special One-Time Settlement (SOTS) scheme to pharma companies for fast track recovery...

PLI Scheme for Intermediates and APIs approved

PLI Scheme for Intermediates and APIs approved The Applications of following companies, which have committed more than the minimum...

Pharma marketing: Govt soon to share draft Uniform Code

Even as the Department of Pharmaceuticals (DoP) has been seeking compliance reports from industry regarding implementation of the Uniform Code of Pharmaceutical...

DoP issues revised guidelines for procurement of drugs

Revised guidelines for procurement of drugs The Department of Pharmaceuticals (DoP) recently issued revised guidelines of Public Procurement Order...

Medical devices industry seeks clarity on PLI scheme

The medical devices industry has sought clarity on the Central government’s claim that medical device sector has been adequately covered under the...

DoP: Revised guidelines for procurement of medical devices

The Department of Pharmaceuticals (DoP) has issued revised guidelines for implementing the provisions of public procurement (preference to Make in India) Order...

DoP issues letter to Pharma Associations to ensure adherence to UCPMP

The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry’s key associations, namely; IDMA, BDMA, IPA, OPPI and FOPE...

Revised PLI scheme guidelines to be launched: DoP

The Department of Pharmaceuticals (DoP)plans to launch revised PLI scheme guidelines. It is likely that in the revised PLI...

Pharma PLI scheme: 29 Cos applied so far to take benefits

The initial response to the four schemes launched by the Department of Pharmaceuticals (DoP) for promoting domestic manufacturing of drugs, APIs/ KSMs...

10 pharma clusters to meet global regulatory standards: DoP

In a bid to encourage pharma MSMEs to equip themselves to meet the regulatory requirements of Pharmaceutical Inspection Cooperation Scheme (PICS), the...

Future pharma policies to be PICS member: DoP

The Department of Pharmaceuticals (DoP) plans to design future policies for the pharma sector keeping in mind the vision of becoming a...

Brief guidelines for bulk drug parks: DoP

The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilisers, the Government of India has issued brief guidelines for bulk...

Latest posts

Lab में बनाया नया Mini Brain, इन बीमारियों का इलाज होगा...

Lab में बनाया नया Mini Brain, इन बीमारियों का इलाज होगा Easy A new type of ‘Mini Brain’...

Authors

52 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS